> Skip repeated content

Vivian Bykerk, MD: Biologic Therapies versus Conventional Disease-Modifying Anti-Rheumatic Drugs

The Center for Biosimilars—July 30, 2018

The Center for Biosimilars interviewed HSS rheumatologist Vivian P. Bykerk, BSc, MD, FRCPC, on the difference between biologic therapies and conventional disease-modifying anti-rheumatic drugs (DMARDs).

"We like the conventional DMARDs, but the problem with them is some people have side effects, as they could have side effects to anything. It’s hard to remember always to take the medication. There are some conventional DMARDs you have to take 4, 6 times a day, which is not so easy," said Dr. Bykerk.

However, she explained that the DMARD methotrexate helps reduce the body’s rejection of biologics.

"We see in study after study after study, that when you combine methotrexate and a biologic, even if the methotrexate is at a lower dose, those people do better over time," Dr. Bykerk added.

Watch the full video interview at centerforbiosimilars.com.

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts